Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
For a dedicated overview of the facial volume changes associated with GLP-1 use, see the Ozempic face guide
Portion Control: Even healthy foods can hinder weight loss if you overeat
Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD
An addition to the Optum Rx Concurrent Drug Utilization Review (cDUR) program, the new solution uses Duplicate Therapy (DUPTHER) screening to ensure members are using appropriate doses of GLP-1 medications
Ideally, youll never miss a dose